Alkem Laboratories Limited
ALKEM
Rank in Stocks
#2830
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Share Price
$55.19
Market Cap
$6.60B
Change (1 day)
-0.06%
Change (1 year)
-12.43%
Country
IN
Trade Alkem Laboratories Limited (ALKEM)
Category
Healthcare
Number of shares outstanding for Alkem Laboratories Limited (ALKEM)
Number of shares outstanding as of June 2026: 119.57M
According to Alkem Laboratories Limited latest financial reports and stock price the company's current number of shares outstanding is 119.57M. At the end of March 2024 the company had 119.57M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Alkem Laboratories Limited (ALKEM) from 2010 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 119.57M | 0.00% |
| 2025 | 119.57M | 0.00% |
| 2024 | 119.57M | 0.00% |
| 2023 | 119.57M | 0.00% |
| 2022 | 119.57M | 0.00% |
| 2021 | 119.57M | 0.00% |
| 2020 | 119.57M | 0.00% |
| 2019 | 119.57M | 0.00% |
| 2018 | 119.57M | 0.00% |
| 2017 | 119.57M | 0.00% |
| 2016 | 119.57M | 0.00% |
| 2015 | 119.57M | 0.00% |
| 2014 | 119.57M | 0.00% |
| 2013 | 119.57M | 0.00% |
| 2012 | 119.57M | 0.00% |
| 2011 | 119.57M | -0.01% |
| 2010 | 119.58M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,906.72% |
IN
|
